Lyell Immunopharma
Price & Volume
Stats
See moreOpen | $14.66 |
Previous Close | $14.33 |
Day Range | $13.52-$14.66 |
52W Range | $9.11-$45 |
Market Cap | $350.2M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $31,000 |
Revenue Growth (YoY) | -71.4% |
Gross Profit (12 Mos) | $31,000 |
Diluted EPS | -$13.62 |
News
See moreYahoo Finance • last month
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
Yahoo Finance • 7 months ago
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Yahoo Finance • 7 months ago
Lyell's Ronde-cel Shows Durable Complete Responses With Manageable Safety In High-Risk LBCL
About
CEO | Dr. Lynn Seely M.D., Ph.D. |
CFO | Ms. Smital Shah M.B.A. |
Address | 201 Haskins Way, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |